Venous Compression in Fontan
University of Texas Southwestern Medical Center · NCT07220226
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–45 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 20
- US sites recruiting
- 1
- Study start
- May 10, 2026
- Record last updated
- July 30, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The aim of this study is to investigate whether venous compression garments increase exercise stroke volume in patients with Fontan circulation. To address this aim, we will test the following hypotheses:
- Acute and chronic external venous compression will increase exercise stroke volume in patients with Fontan circulation.
- Patients with significant venous varicosities will have a greater response to venous compression.
Participants will
- Undergo submaximal exercise testing in MRI to measure venous return and exercise stroke volume with and without the wearing of compression garments
- Undergo submaximal exercise testing on a seated upright exercise ergometer with concurrent measurement of stroke volume with and without the wearing of compression garments
- A subset of participants will repeat both testing visits after wearing compression garments for 2-weeks during waking hours.
Participants will
- Undergo submaximal exercise testing in MRI to measure venous return and exercise stroke volume with and without the wearing of compression garments
- Undergo submaximal exercise testing on a seated upright exercise ergometer with concurrent measurement of stroke volume with and without the wearing of compression garments
- A subset of participants will repeat both testing visits after wearing compression garments for 2-weeks during waking hours.
Being studied: Lower extremity compression garments; Without compression garments
Conditions: Single-ventricle; Fontan Circulation
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Patients with a Fontan circulation -
Inclusion criteria
- Patients at UTSW aged 18-45 years old with a Fontan circulation.
Exclusion Criteria
- NYHA Class 4
- Severe AV valve regurgitation
- Severe ventricular dysfunction
- Large ascites
- Significant varicosities
- Atrio-pulmonary (AP) Fontan
- Known Fontan thrombus
- Poorly controlled arrythmia
- Unplanned cardiac admission in the last 6 months
- Cyanosis (resting O2 saturation \<85%)
- Pregnant
- Common femoral vein obstruction >50% to be performed following completion of informed consent.
Healthy Controls
Healthy control participants will be recruited on the basis of having no known chronic diseases and not currently taking any cardiovascular medications.
Recruiting US locations
UT Southwestern Medical Center
Dallas, TX 75390
Site contact: Keval Patel, M.D. · 214-345-4670 · keval.patel@utsouthwestern.edu
Study contacts (from the official record)
- Keri Shafer, MD · 2146451165 · keri.shafer@utsouthwestern.edu
- Denis J Wakeham, PhD · 2146451165 · denis.wakeham@utsouthwestern.edu
Similar studies in Texas
All healthy volunteers studies in Texas →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study of LY4355756 in Healthy Participants
Eli Lilly and Company
- Location
- Dallas, TX
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment
AstraZeneca
- Location
- San Antonio, TX + 1 other US site
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight
Eli Lilly and Company
- Location
- San Antonio, TX
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Radiprodil in Participants With Hepatic Impairment
GRIN Therapeutics, Inc.
- Location
- DeSoto, TX + 1 other US site
- Eligibility basics
- Ages 18–75